Author: Jessica.F

Hu, Ming-Hao; Lin, Jia-Hong; Huang, Qiong published the artcile< Discovery of a fluorescent, long chain-bridged bispurine that selectively targets the c-MYC G-quadruplex>, SDS of cas: 452-06-2, the main research area is c MYC VEGF HRAS BCL2; Bispurine; Fluorescent; G-quadruplex; Selective; c-MYC.

G-quadruplexes (G4s) are special nucleic acid structures which are involved in the regulation of some key biol. events like transcription and translation, which are now treated as promising therapeutic targets for cancers. Stabilizing the promoter G4 by small-mol. ligands can suppress the c-MYC oncogene transcription, thus inhibiting cancer cell proliferation. So far, targeting the very structure, a number of ligands have been reported. However, most of them showed unsatisfactory specificity to the c-MYC G4 over other G4s, resulting in uncertain side effects. In this contribution, we discovered a new class of bispurines bridged with flexible hydrocarbon chains, which presented somewhat selectivity to the c-MYC G4 possibly by adaptive binding, which then showed clear inhibition on the c-MYC expression rather than other G4-driven oncogenes. Moreover, these novel mols. had the potential to fluorescently label G4s. We believed that this study may shed light on the discovery of new functional small mols. targeting a specific G4 structure.

Bioorganic Chemistry published new progress about Animal gene Role: BSU (Biological Study, Unclassified), PRP (Properties), BIOL (Biological Study) (HRAS). 452-06-2 belongs to class imidazoles-derivatives, and the molecular formula is C5H5N5, SDS of cas: 452-06-2.

Referemce:
Imidazole – Wikipedia,
Imidazole | C3H4N2 – PubChem

Lin, Yu; Liu, Meihan; Chen, Enqi; Jiang, Wei; Shi, Weidong; Wang, Zhiyuan published the artcile< Bone marrow-derived mesenchymal stem cells microvesicles stabilize atherosclerotic plaques by inhibiting NLRP3-mediated macrophage pyroptosis>, Product Details of C30H30Cl2N6O2, the main research area is bone marrow stem cell microvesicle atherosclerotic plaque NLRP pyroptosis; Nod-like receptor protein 3; atherosclerosis; atherosclerotic plaques; bone marrow-derived mesenchymal stem cells microvesicles; macrophage; microRNA-223; pyroptosis.

Rupture of atherosclerotic plaques constitutes the major cause of thrombosis and acute ischemic coronary syndrome. Bone marrow-derived mesenchymal stem cells microvesicles (BMSCs-MVs) are reported to promote angiogenesis. This study investigated the role of BMSCs-MVs in stabilizing atherosclerotic plaques. The BMSCs-MVs in mice were isolated and identified. The mouse model of atherosclerosis was established, and mice were injected with BMSCs-MVs via the tail vein. The macrophage model with high glucose and oxidative damage was established and then incubated with BMSCs-MVs. Nod-like receptor protein 3 (NLRP3) expression, pyroptosis-related proteins, and inflammatory factors were detected. Actinomycin D was used to inhibit the secretion of BMSCs-MVs to verify the source of microRNA-223 (miR-223). The binding relationship between miR-223 and NLRP3 was predicted and verified. The BMSCs-MVs with knockdown of miR-223 were cocultured with bone marrow-derived macrophages with knockdown of NLRP3, and then levels of miR-223, NLRP3, pyroptosis-related proteins, and inflammatory factors were detected. The BMSCs-MVs could reduce the vulnerability index of atherosclerotic plaques and intima-media thickness in mice, and inhibit pyroptosis and inflammation. The BMSCs-MVs inhibited pyroptosis and inflammatory factors in macrophages. The BMSCs-MVs carried miR-223 to inhibit NLRP3 expression and reduce macrophage pyroptosis, thereby stabilizing the atherosclerotic plaques.

Cell Biology International published new progress about Angiogenesis. 6823-69-4 belongs to class imidazoles-derivatives, and the molecular formula is C30H30Cl2N6O2, Product Details of C30H30Cl2N6O2.

Referemce:
Imidazole – Wikipedia,
Imidazole | C3H4N2 – PubChem

Remington, Jacob M.; McCullagh, Martin; Kohler, Bern published the artcile< Molecular Dynamics Simulations of 2-Aminopurine-Labeled Dinucleoside Monophosphates Reveal Multiscale Stacking Kinetics>, Quality Control of 452-06-2, the main research area is mol dynamics simulation aminopurine dinucleoside monophosphate stacking kinetics.

Mol. dynamics (MD) simulations of 2-aminopurine (2Ap)-labeled DNA dinucleoside monophosphates (DNMPs) were performed to investigate the hypothesis that base stacking dynamics occur on timescales sufficiently rapid to influence the emission signals measured in time-resolved fluorescence experiments Anal. of multiple microsecond-length trajectories shows that the DNMPs sample all four coplanar stacking motifs. In addition, three metastable unstacked conformations are detected. A hidden Markov-state model (HMSM) was applied to the simulations to estimate transition rates between the stacked and unstacked states. Transitions between different stacked states generally occur at higher rates when the number of nucleobase faces requiring desolvation is minimized. Time constants for structural relaxation range between 1.6 and 25 ns, suggesting that emission from photoexcited 2Ap, which has an excited-state lifetime of 10 ns, is sensitive to base stacking kinetics. A master equation model for the excited-state population of 2Ap predicts multiexponential emission decays that reproduce the sub-10 ns emission decay lifetimes and amplitudes seen in experiments Combining MD simulations with HMSM anal. is a powerful way to understand the dynamics that influence 2Ap excited-state relaxation and represents an important step toward using observed emission signals to validate MD simulations.

Journal of Physical Chemistry B published new progress about Conformation. 452-06-2 belongs to class imidazoles-derivatives, and the molecular formula is C5H5N5, Quality Control of 452-06-2.

Referemce:
Imidazole – Wikipedia,
Imidazole | C3H4N2 – PubChem

Hua, Zihao; Huang, Xin; Bregman, Howard; Chakka, Nagasree; DiMauro, Erin F.; Doherty, Elizabeth M.; Goldstein, Jon; Gunaydin, Hakan; Huang, Hongbing; Mercede, Stephanie; Newcomb, John; Patel, Vinod F.; Turci, Susan M.; Yan, Jie; Wilson, Cindy; Martin, Matthew W. published the artcile< 2-(Phenylamino)-6-cyano-1H-benzimidazole-based isoform selective casein kinase 1 gamma (CK1γ) inhibitors>, HPLC of Formula: 401567-00-8, the main research area is phenylamino cyano benzimidazole preparation casein kinase inhibitor treatment cancer.

Screening of the amgen compound library led to the identification of 2-(phenylamino)-6-cyano-1H-benzimidazole, I, as a potential CK1 gamma inhibitor (CK1γ) with excellent kinase selectivity and unprecedented CK1 isoform selectivity. Further structure-based optimization of this series resulted in the discovery of II, which possessed good enzymic and cellular potency, excellent CK1 isoform and kinase selectivity, and acceptable pharmacokinetic properties.

Bioorganic & Medicinal Chemistry Letters published new progress about Antitumor agents. 401567-00-8 belongs to class imidazoles-derivatives, and the molecular formula is C8H4ClN3, HPLC of Formula: 401567-00-8.

Referemce:
Imidazole – Wikipedia,
Imidazole | C3H4N2 – PubChem

Gilmore, John L.; Xiao, Hai-Yun; Dhar, T. G. Murali; Yang, Michael G.; Xiao, Zili; Xie, Jenny; Lehman-McKeeman, Lois D.; Gong, Lei; Sun, Huadong; Lecureux, Lloyd; Chen, Cliff; Wu, Dauh-Rurng; Dabros, Marta; Yang, Xiaoxia; Taylor, Tracy L.; Zhou, Xia D.; Heimrich, Elizabeth M.; Thomas, Rochelle; McIntyre, Kim W.; Borowski, Virna; Warrack, Bethanne M.; Li, Yuwen; Shi, Hong; Levesque, Paul C.; Yang, Zheng; Marino, Anthony M.; Cornelius, Georgia; D’Arienzo, Celia J.; Mathur, Arvind; Rampulla, Richard; Gupta, Anuradha; Pragalathan, Bala; Shen, Ding Ren; Cvijic, Mary Ellen; Salter-Cid, Luisa M.; Carter, Percy H.; Dyckman, Alaric J. published the artcile< Identification and preclinical pharmacology of ((1R,3S)-1-amino-3-((S)-6-(2-methoxyphenethyl)-5,6,7,8-tetrahydronaphthalen-2-yl)cyclopentyl)methanol (BMS-986166): a differentiated sphingosine-1-phosphate receptor 1 (S1P1) modulator advanced into clinical trials>, HPLC of Formula: 1003-21-0, the main research area is sphingosine 1 phosphate receptor pharmacokinetics arthritis antiarthritic multiple sclerosis; crystal structure.

Recently, our research group reported the identification of BMS-986104 (2) as a differentiated S1P1 receptor modulator. In comparison to fingolimod (1), a full agonist of S1P1 currently marketed for the treatment of relapse remitting multiple sclerosis (RRMS), 2 offers several potential advantages having demonstrated improved safety multiples in preclin. evaluations against undesired pulmonary and cardiovascular effects. In clin. trials, 2 was found to exhibit a pharmacokinetic half-life (T1/2) longer than that of 1, as well as a reduced formation of the phosphate metabolite that is required for activity against S1P1. Herein, we describe our efforts to discover highly potent, partial agonists of S1P1 with a shorter T1/2 and increased in vivo phosphate metabolite formation. These efforts culminated in the discovery of ((1R,3S)-1-amino-3-((S)-6-(2-methoxyphenethyl)-5,6,7,8-tetrahydronaphthalen-2-yl)cyclopentyl)methanol [1883345-06-9] (BMS-986166, 14a), which was advanced to human clin. evaluation. The pharmacokinetic/pharmacodynamic (PK/PD) relationship as well as pulmonary and cardiovascular safety assessments are discussed. Furthermore, efficacy of BMS-986166 in multiple preclin. models of autoimmune diseases are presented.

Journal of Medicinal Chemistry published new progress about Anti-multiple sclerosis agents. 1003-21-0 belongs to class imidazoles-derivatives, and the molecular formula is C4H5BrN2, HPLC of Formula: 1003-21-0.

Referemce:
Imidazole – Wikipedia,
Imidazole | C3H4N2 – PubChem

Li, Yue; Liu, Yukang; Singh, Jaideep; Tangprasertchai, Narin S.; Trivedi, Ravi; Fang, Yun; Qin, Peter Z. published the artcile< Site-Specific Labeling Reveals Cas9 Induces Partial Unwinding Without RNA/DNA Pairing in Sequences Distal to the PAM>, Reference of 452-06-2, the main research area is RNA DNA pairing PAM Cas9.

CRISPR-Cas9 is an RNA-guided nuclease that has been widely adapted for genome engineering. A key determinant in Cas9 target selection is DNA duplex unwinding to form an R-loop, in which the single-stranded RNA guide hybridizes with one of the DNA strands. To advance understanding on DNA unwinding by Cas9, we combined two types of spectroscopic label, 2-aminopurine and nitroxide spin-label, to investigate unwinding at a specific DNA base pair induced by Streptococcus pyogenes Cas9. Data obtained with RNA guide lengths varying from 13 to 20 nucleotide revealed that the DNA segment distal to the protospacer adjacent motif can adopt a “”partial unwinding”” state, in which a mixture of DNA-paired and DNA-unwound populations exist in equilibrium Significant unwinding can occur at positions not supported by RNA/DNA pairing, and the degree of unwinding depends on RNA guide length and modulates DNA cleavage activity. The results shed light on Cas9 target selection and may inform developments of genome-engineering strategies.

CRISPR Journal published new progress about Demography. 452-06-2 belongs to class imidazoles-derivatives, and the molecular formula is C5H5N5, Reference of 452-06-2.

Referemce:
Imidazole – Wikipedia,
Imidazole | C3H4N2 – PubChem

Liu, Tao; Chen, Gang; Sun, Dawei; Lei, Minghui; Li, Yongqiang; Zhou, Changming; Li, Xiaodong; Xue, Wei; Wang, Hong; Liu, Chunjun; Xu, Jiang published the artcile< Exosomes containing miR-21 transfer the characteristic of cisplatin resistance by targeting PTEN and PDCD4 in oral squamous cell carcinoma>, Application In Synthesis of 6823-69-4, the main research area is exosome miR21 anticancer cisplatin resistance oral squamous cell carcinoma; cisplatin resistance; exosome; miR-21; oral squamous cell carcinoma.

Resistance to chemotherapy remains a major obstacle for the effective treatment of oral squamous cell carcinoma (OSCC). Evidence for the involvement of exosomes as important regulators of cisplatin chemoresistance in OSCC is still poorly understood. Our objective of this study was to explore the roles for exosomes in modulating key cellular pathways mediating response to chemotherapy. We first developed the cisplatin-resistant cell lines (HSC-3-R and SCC-9-R) and found that the conditioned media from cisplatin-resistant OSCC cells enhanced the chemoresistance of parental OSCC cell. The release of exosomes was blocked by inhibitor (GW4869) and exosomes were found to be involved in the chemoresistance of parental OSCC cell transferred from resistant cells. The exosomes derived from resistant cells and parental cells were isolated. Then, the isolated exosomes were characterized and quantified by electron microscopy, qNano anal., and western blot anal. Exosomes derived from cisplatin-resistant OSCC cells were found to enhance the chemoresistance of OSCC cell and decrease the DNA damage signaling in response to cisplatin. It was also found that exosomes derived from cisplatin-resistant OSCC cells transferred miR-21 to OSCC parental cells and induced cisplatin resistance by targeting phosphatase and tensin homolog and programmed cell death 4. Furthermore, the roles of cisplatin-resistant OSCC cells-derived exosomes in vivo were confirmed by s.c. xenograft mouse model.Collectively, the results suggest that exosomes released from cisplatin-resistant OSCC cells transmit miR-21 to induce cisplatin resistance of OSCC cells.

Acta Biochimica et Biophysica Sinica published new progress about Antitumor agents. 6823-69-4 belongs to class imidazoles-derivatives, and the molecular formula is C30H30Cl2N6O2, Application In Synthesis of 6823-69-4.

Referemce:
Imidazole – Wikipedia,
Imidazole | C3H4N2 – PubChem

Shin, Yeonoh; Hedglin, Mark; Murakami, Katsuhiko S. published the artcile< Structural basis of reiterative transcription from the pyrG and Pyrbi promoters by bacterial RNA polymerase>, HPLC of Formula: 452-06-2, the main research area is gene transcription pyrG Pyrbi bacteria RNA polymerase crystal structure.

Reiterative transcription is a non-canonical form of RNA synthesis by RNA polymerase in which a ribonucleotide specified by a single base in the DNA template is repetitively added to the nascent RNA transcript. We previously determined the X-ray crystal structure of the bacterial RNA polymerase engaged in reiterative transcription from the pyrG promoter, which contains eight poly-G RNA bases synthesized using three C bases in the DNA as a template and extends RNA without displacement of the promoter recognition σ factor from the core enzyme. In this study, we determined a series of transcript initiation complex structures from the pyrG promoter using soak-trigger-freeze X-ray crystallog. We also performed biochem. assays to monitor template DNA translocation during RNA synthesis from the pyrG promoter and in vitro transcription assays to determine the length of poly-G RNA from the pyrG promoter variants. Our study revealed how RNA slips on template DNA and how RNA polymerase and template DNA determine length of reiterative RNA product. Lastly, we determined a structure of a transcript initiation complex at the pyrBI promoter and proposed an alternative mechanism of RNA slippage and extension requiring the σ dissociation from the core enzyme.

Nucleic Acids Research published new progress about Bacillus subtilis. 452-06-2 belongs to class imidazoles-derivatives, and the molecular formula is C5H5N5, HPLC of Formula: 452-06-2.

Referemce:
Imidazole – Wikipedia,
Imidazole | C3H4N2 – PubChem

Volpe, Andrea; Natali, Mirco; Graiff, Claudia; Sartorel, Andrea; Tubaro, Cristina; Bonchio, Marcella published the artcile< Novel iridium complexes with N-heterocyclic dicarbene ligands in light-driven water oxidation catalysis: photon management, ligand effect and catalyst evolution>, Recommanded Product: 5-Bromo-1-methyl-1H-imidazole, the main research area is imidazolylidene silver dicarbene complex transmetalation cyclopentadienyl iridium chloride; iridium imidazolylidene dicarbene complex preparation catalyst water oxidation kinetics; crystal structure imidazolylidene cyclopentadienyliridium dicarbene complex; mol structure imidazolylidene cyclopentadienyliridium dicarbene complex.

Ir complexes [IrClCp*diNHC]PF6, with N-heterocyclic dicarbene (diNHC) and pentamethylcyclopentadienyl (Cp*) ligands, were studied in light driven H2O oxidation catalysis within the Ru(bpy)32+/S2O82- cycle (bpy = 2,2′-bipyridine). In particular, the effect of different diNHC ligands was evaluated by employing the complex 1a (diNHC = 1,1′-dimethyl-3,3′-ethylenediimidazol-2,2′-diylidene) and the novel and structurally characterized 2 (diNHC = 1,1′-dimethyl-3,3′-ethylene-5,5′-dibromodiimidazol-2,2′-diylidene) and 3 (diNHC = 1,1′-dimethyl-3,3′-ethylene-dibenzimidazol-2,2′-diylidene). The presented results include: (i) a photon management anal. of the 1a/Ru(bpy)32+/S2O82- system, revealing two regimes of O2 evolution rate, being dependent on the light intensity at low photon flux, where the system reaches an overall quantum yield up to 0.17 ± 0.01 (quantum efficiency 34 ± 2%), while being independent of light intensity at high photon flux thus indicating a change of limiting step; (ii) a trend of O2 evolution activity that follows the order 1a > 2 > 3 both under low and high photon flux conditions, with the reactivity that is favored by the electron donating nature of the diNHC ligand, quantified from the carbene C chem. shift; (iii) an analogous trend also in the bimol. rate constants of electron transfer kET from the Ir species to photogenerated Ru(bpy)33+, with kET values in the range 4.2-6.1 × 104 M-1 s-1, thus implying a significant reorganization energy to the Ir sphere; (iv) the evolution of 1a, as the most active Ir species in the series, to mononuclear Ir species with lower mol. weight and originating from oxidative transformation of the organic ligand scaffold, as proven by converging UV-visible, MALDI-MS and 1H-NMR evidences. These results can be used for the further design and engineering of novel catalysts.

Dalton Transactions published new progress about Carbene complexes Role: CAT (Catalyst Use), PRP (Properties), SPN (Synthetic Preparation), USES (Uses), PREP (Preparation) (cyclopentadienyl Ir complexes). 1003-21-0 belongs to class imidazoles-derivatives, and the molecular formula is C4H5BrN2, Recommanded Product: 5-Bromo-1-methyl-1H-imidazole.

Referemce:
Imidazole – Wikipedia,
Imidazole | C3H4N2 – PubChem

Wickhorst, Peter Jonas; Ihmels, Heiko; Paululat, Thomas published the artcile< Studies on the Interactions of 3,11-Difluoro-6,8,13-trimethyl-8H-quino[4,3,2-kl]acridinium and Insulin with the Quadruplex-Forming Oligonucleotide Sequence a2 from the Insulin-Linked Polymorphic Region>, Quality Control of 452-06-2, the main research area is interaction quadruplex oligonucleotide sequence insulin linked polymorphic region; DNA recognition; ILPR; spectroscopic methods.

Recently, several quadruplex-DNA-forming sequences have been identified in the insulin-linked polymorphic region (ILPR), which is a guanine-rich oligonucleotide sequence in the promoter region of insulin. The formation of this non-canonical quadruplex DNA (G4-DNA) has been shown to be involved in the biol. activity of the ILPR, specifically with regard to its interplay with insulin. In this context, this contribution reports on the investigation of the association of the quadruplex-forming ILPR sequence a2 with insulin as well as with the well-known G4-DNA ligand 3,11-difluoro-6,8,13-trimethyl-8H-quino[4,3,2-kl]acridinium (1), also named RHPS4, by optical and NMR spectroscopy. CD- and NMR-spectroscopic measurements confirmed the preferential formation of an antiparallel quadruplex structure of a2 with four stacked guanine quartets. Furthermore, ligand 1 has high affinity toward a2 and binds by terminal π stacking to the G1-G11-G15-G25 quartet. In addition, the spectroscopic studies pointed to an association of insulin to the deoxyribose backbone of the loops of a2.

Molecules published new progress about Absorption. 452-06-2 belongs to class imidazoles-derivatives, and the molecular formula is C5H5N5, Quality Control of 452-06-2.

Referemce:
Imidazole – Wikipedia,
Imidazole | C3H4N2 – PubChem